Year: 2022
Type: article
Abstract: CAR T cell therapy is an effective cancer treatment, but biological and manufacturing hurdles hamper its broad breakthrough. Although the first step towards automated manufacture of CAR cells has been taken, new technologies are needed to enable the treatment of large patient groups.
Source: Nature Communications
Authors: Ulrich Blache, Georg Popp, Anna Dünkel, Ulrike Koehl, Stephan Fricke
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,890
OpenAlex ID: W4294679595
